GR1004012B - Once-a-day pharmaceutical composition containing brivudine - Google Patents

Once-a-day pharmaceutical composition containing brivudine

Info

Publication number
GR1004012B
GR1004012B GR20010100322A GR2001100322A GR1004012B GR 1004012 B GR1004012 B GR 1004012B GR 20010100322 A GR20010100322 A GR 20010100322A GR 2001100322 A GR2001100322 A GR 2001100322A GR 1004012 B GR1004012 B GR 1004012B
Authority
GR
Greece
Prior art keywords
once
pharmaceutical composition
composition containing
brivudine
day pharmaceutical
Prior art date
Application number
GR20010100322A
Other languages
Greek (el)
Other versions
GR20010100322A (en
Inventor
Alessandro Casini
Attilio Crea
Bettina Stubinski
Original Assignee
Berlin-Chemie Ag
Menarini Ricerche S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin-Chemie Ag, Menarini Ricerche S.P.A. filed Critical Berlin-Chemie Ag
Publication of GR20010100322A publication Critical patent/GR20010100322A/en
Publication of GR1004012B publication Critical patent/GR1004012B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

here is disclosed the activity of brivudine once-a-day in acute herpes zoster infections and post-herpetic neuralgia and the compositions thereof.
GR20010100322A 2001-01-03 2001-07-05 Once-a-day pharmaceutical composition containing brivudine GR1004012B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (en) 2001-01-03 2001-01-03 PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (2)

Publication Number Publication Date
GR20010100322A GR20010100322A (en) 2002-10-08
GR1004012B true GR1004012B (en) 2002-11-01

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100322A GR1004012B (en) 2001-01-03 2001-07-05 Once-a-day pharmaceutical composition containing brivudine

Country Status (20)

Country Link
AT (1) AT6141U1 (en)
BE (1) BE1014522A5 (en)
CH (1) CH695662A5 (en)
CZ (1) CZ20012464A3 (en)
DK (1) DK177084B1 (en)
ES (1) ES2192456B1 (en)
FI (1) FI20011446A (en)
FR (1) FR2818907B1 (en)
GB (1) GB2370771A (en)
GR (1) GR1004012B (en)
HR (1) HRPK20010345B3 (en)
HU (1) HUP0102816A3 (en)
IE (1) IE20010413A1 (en)
IT (1) ITMI20010009A1 (en)
NL (1) NL1018431C2 (en)
PL (1) PL348480A1 (en)
PT (1) PT102642B (en)
SE (1) SE0102309L (en)
SK (1) SK287043B6 (en)
UA (1) UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (en) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) * 1983-10-31 1987-06-03 Anna Gioia Stendardi THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
DK0874631T3 (en) * 1996-01-19 2004-03-22 Glaxo Group Ltd Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes in a single daily application

Also Published As

Publication number Publication date
HRPK20010345B3 (en) 2005-02-28
GB0110682D0 (en) 2001-06-20
ITMI20010009A0 (en) 2001-01-03
FR2818907B1 (en) 2006-05-26
DK177084B1 (en) 2011-07-11
BE1014522A5 (en) 2003-12-02
FR2818907A1 (en) 2002-07-05
CZ20012464A3 (en) 2002-08-14
DK200101019A (en) 2002-07-04
SK287043B6 (en) 2009-10-07
GR20010100322A (en) 2002-10-08
PT102642A (en) 2002-07-31
IE20010413A1 (en) 2003-04-16
SK9572001A3 (en) 2003-03-04
HUP0102816A3 (en) 2005-01-28
PT102642B (en) 2003-06-30
NL1018431C2 (en) 2002-07-05
ES2192456B1 (en) 2005-02-01
ES2192456A1 (en) 2003-10-01
GB2370771A (en) 2002-07-10
AT6141U1 (en) 2003-05-26
PL348480A1 (en) 2002-07-15
HU0102816D0 (en) 2001-09-28
FI20011446A (en) 2002-07-04
HRP20010345A2 (en) 2003-08-31
CH695662A5 (en) 2006-07-31
ITMI20010009A1 (en) 2002-07-03
FI20011446A0 (en) 2001-07-03
UA76402C2 (en) 2006-08-15
SE0102309D0 (en) 2001-06-28
SE0102309L (en) 2002-07-04
HUP0102816A2 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
HUP0500163A3 (en) Pyrazolo [5,1-b]quinazoline derivatives and pharmaceutical compositions thereof as inhibitors of impdh enzyme
ITRM980103A0 (en) USE OF BACTERIA EQUIPPED WITH ARGININE DEIMINASE TO INTRODUCE APOSTOSIS AND/OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS
ATE263558T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITORS AND CHITOSAN
DE69925133D1 (en) PYRROLOBENZODIAZEPINE
GEP20022786B (en) Purine Inhibitors of Cyclin Dependent Kinase 2 and 1kB-a
HUP0200403A2 (en) Pyrrolopyrimidines as protein kinase inhibitors, pharmaceutical compositions containing them and their use
RS49995B (en) The use of dialkyl fumarates
ES2149276T3 (en) IMIDAZO (4,5-C) PIRIDIN-4-AMINAS.
ES2161548T3 (en) COMBINATION OF AN INHIBITOR OF ALDOSA REDUCTASA AND AN INHIBITOR OF GLUCOGENO FOSFORILASA.
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
GEP20053479B (en) Pyrrolo[2,3-d]Pyrimidine Compounds, Pharmaceutical Composition Containing the Same and Use
IS1940B (en) Pharmaceutical formulations containing HMG reducing enzyme inhibitors
BR0013081A (en) Metalloproteinase-inhibiting pyrimidine-2,4,6-triones
ITMI942025A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ENGINEERED MICROORGANISMS AND THEIR USE FOR THERAPY
DE60005493D1 (en) Pyrimido [6,1-A] ISOCHINOLINONDERIVATE
AU2284299A (en) Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
ATE302746T1 (en) AMORPHOUS NITRIC ESTERS AND THEREOF PHARMACEUTICAL COMPOSITIONS
ATE401896T1 (en) PHARMACEUTICAL COMPOSITIONS WITH TUMOR NECROSIS FACTOR AND 2-METHOXYESTRON-3-O-SULPHAMAT AS ESTRONE SULPHATASE INHIBITORS
CA2429639A1 (en) Stable azithromycin monohydrate
ATE268175T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DECURSIN
TR200101493T2 (en) Eletriptan hydrobromide monohydrate
BR0012184B1 (en) indole-derived compounds, pharmaceutical formulation, and composition and use of the compounds in the manufacture of medicaments
GR20010100322A (en) Once-a-day pharmaceutical composition containing brivudine
AR030853A1 (en) PESTICIDE COMPOSITION
HUP0202744A2 (en) Oral controlled release formulations containing rivastigmine